Does RIVAROXABAN Cause Stent placement? 122 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Stent placement have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.
122
Reports of Stent placement with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
3
Deaths
46
Hospitalizations
How Dangerous Is Stent placement From RIVAROXABAN?
Of the 122 reports, 3 (2.5%) resulted in death, 46 (37.7%) required hospitalization, and 3 (2.5%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
FLUTICASONE\SALMETEROL (105)
Which RIVAROXABAN Alternatives Have Lower Stent placement Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM